An adverse finding will result in the BMA taking one or more of the actions outlined in Section EN-8.1. All adverse findings have to be approved by an Executive Director of the BMA. Once approved, a notice of intent is issued to the Board/senior management of the licensee and copied to the person concerned, setting out the circumstances and the basis for the BMA's proposed adverse finding. The licensee has 30 calendar days from the date of the notice in which to make written representations, addressed to the Executive Director concerned, failing which a final notice is issued by the BMA. During this 30-day period, the person is suspended from the controlled function(s) specified in the notice (but not from performing other functions for the licensee, unless specified in the notice), and the licensee must immediately contact the BMA to discuss how the controlled function will be filled in the interim.